We are live on ! Find out more
BMRN icon

BioMarin Pharmaceuticals
BMRN

280 hedge funds and large institutions have $7.98B invested in BioMarin Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 280 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

16% less call options, than puts

Call options by funds: $36.2M | Put options by funds: $43M

Holders
280
Holders Change
+280
Holders Change %
–
% of All Funds
9.14%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
280
Increased
–
Reduced
–
Closed
–
Calls
$36.2M
Puts
$43M
Net Calls
-$6.77M
Net Calls Change
-$6.77M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
76
Susquehanna International Group
Pennsylvania
$11.5M +$12.8M +205,891 New
DCM
77
Driehaus Capital Management
Illinois
$11.2M +$12.5M +199,940 New
MCM
78
McKinley Capital Management
Alaska
$11M +$12.3M +197,279 New
Axa
79
Axa
France
$10.9M +$12.2M +195,398 New
EAM
80
Eagle Asset Management
Florida
$10.8M +$12.1M +193,936 New
GC
81
Guggenheim Capital
Illinois
$10.6M +$11.8M +189,594 New
TCM
82
Tang Capital Management
California
$10.2M +$11.4M +182,300 New
BB
83
BB Biotech
Switzerland
$9.92M +$11.1M +178,028 New
PPA
84
Parametric Portfolio Associates
Washington
$9.67M +$10.8M +173,560 New
Dimensional Fund Advisors
85
Dimensional Fund Advisors
Texas
$9.43M +$10.5M +169,050 New
MTB
86
Mizuho Trust & Banking
Japan
$9.36M +$10.5M +167,806 New
RFC
87
Russell Frank Company
Washington
$8.87M +$9.91M +159,041 New
Wellington Management Group
88
Wellington Management Group
Massachusetts
$8.77M +$9.8M +157,183 New
Public Employees Retirement Association of Colorado
89
Public Employees Retirement Association of Colorado
Colorado
$8.68M +$9.69M +155,510 New
Barclays
90
Barclays
United Kingdom
$8.44M +$9.44M +151,476 New
SCM
91
Shelton Capital Management
Colorado
$8.36M +$9.35M +150,000 New
BJ
92
BlackRock Japan
Japan
$8.27M +$9.25M +148,433 New
Charles Schwab
93
Charles Schwab
California
$8.26M +$8.66M +139,025 New
Bank of America
94
Bank of America
North Carolina
$8.18M +$9.14M +146,727 New
QCMC
95
Quantum Capital Management (California)
California
$7.67M +$8.58M +137,628 New
RhumbLine Advisers
96
RhumbLine Advisers
Massachusetts
$7.61M +$8.5M +136,464 New
Swiss National Bank
97
Swiss National Bank
Switzerland
$7.49M +$8.36M +134,200 New
WC
98
Weatherbie Capital
Massachusetts
$7.41M +$8.28M +132,942 New
NFA
99
Nationwide Fund Advisors
Ohio
$7.11M +$7.94M +127,352 New
STC
100
SEI Trust Company
Pennsylvania
$7.05M +$7.87M +126,290 New
2 3
4
5 6

BMRN Hedge Fund Activity: Q2 2013 in Review

280 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in BioMarin Pharmaceuticals (BMRN) for Q2 2013, worth a combined $7.98B.

Buyers outnumbered sellers: 280 funds opened new BMRN positions and 0 closed out — a net gain of 280 holders — while 0 added to existing stakes and 0 trimmed.

  • 280 institutional investors held BioMarin Pharmaceuticals (BMRN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $7.98B of BioMarin Pharmaceuticals stock for Q2 2013.
  • 280 funds opened new BioMarin Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +280 holders.

Based on aggregated 13F filings for Q2 2013.